| abstract |
The invention relates to the field of medical technology, and discloses the application of the compound represented by formula I in the preparation of STAT3 inhibitors and a STAT3 inhibitor. The compound of formula I in the invention can significantly inhibit acute and chronic leukemia, multiple myeloma, and lymphoma Proliferation and survival of various tumor cells such as lung cancer, prostate cancer and cervical cancer, inhibit tumor cell STAT3 signaling pathway, activate related factors that induce tumor cell apoptosis, thereby inducing tumor cell apoptosis and achieving the effect of treating tumor diseases. |